The Company Reaffirms Full Year 2025 Guidance: Revenue Growth of 8-10% and Adjusted EBITDA (non-GAAP) margin greater than 18.8% ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care...
InfuSystem Announces Operational and Financial Results for Fourth Quarter and Full Year 2024
Full Year 2024 vs. Full Year 2023: Record Net Revenues: $134.9 million, a 7% increase Patient Services Revenue: $80.4 million - Device Solutions Revenue: $54.5 million, increases of 5% and 11% Adjusted EBITDA (non-GAAP): $25.3 million, a 13% increase Record Operating...
InfuSystem to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
InfuSystem to Present at Sidoti Small Cap Conference on December 4, 2024
Investor Presentation to be held at 10:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
InfuSystem Appoints Ronald Hundzinski to the Board of Directors
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced...
InfuSystem Reports Third Quarter 2024 Financial Results
Record Net Revenues of $35.3 million Representing 11% Growth from the Prior Year Net income of $1.8 million, an increase of 162% Adjusted EBITDA (non-GAAP) margin expanded by 2.8% to 22% Reaffirms Full-Year 2024 Guidance ROCHESTER HILLS, Mich. - InfuSystem Holdings,...
InfuSystem to Report Third Quarter 2024 Financial Results on November 7, 2024
Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical...
InfuSystem Holdings (INFU) Fireside Chat
During this fireside chat Joe Dorame, Managing Partner, Lytham Partners, and Brooks O'Neil, Lake Street Capital Markets chat with Richard DiIorio, Chief Executive Officer of InfuSystem Holdings, Inc. InfuSystem (NYSE American: INFU) is a leading national health care...
InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024
Fireside Chat to be held at 3:30pm ET ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers...
InfuSystem and Sanara MedTech Inc. Announce Exclusive United States Distribution Agreement with ChemoMouthpiece, LLC
ROCHESTER HILLS, Mich. - InfuSystem Holdings, Inc. (NYSE American: INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, and its joint...